Treatment Breast Invasive Web Algorithm

← Back to document page

Department of Clinical Effectiveness V16Approved by Executive Committee of the Medical Staff on 09/15/2020Page 1 of 24Breast Cancer Invasive1 Stage I-III2Disclaimer: This Algorithm has been developed for MD Anderson using a multidisciplinary approach considering circumstances particular to MD Anderson s specific patient population, services and structure, and clinical information. This is not intended to replace the independent medical or professional judgment of physicians or other health care providers in the context of individual clinical circumstances to determine a patient's care. This Algorithm should not be used to treat pregnant 2Hormone receptor- 3 Hormone receptor-positive/HER2-positive or Hormone receptor- 4Hormone receptor-negative/HER2-negative (triple negative Breast cancer)................................. ........................................ .......Page 5Evaluation During and Post Neoadjuvant 6Radiation 8Evaluation for Local 9 Appendix A: Genomic Considerations for Determination of Prognosis and Need for Adjuvant Chemotherapy in Patients with HR+ Breast 10Appendix B: Neoadjuvant/Adjuvant Systemic Therapy 11Appendix C: Endocrine Systemic Neoadjuvant/Adjuvant Therapy 12Appendix D: Selection of Patients for Radiation to Regional 13Appendix E: Recurrent Systemic Therapy Treatment 14Principles of Breast Oncologic 15-17Suggested 18-22 Developm

Sep 15, 2020 · 2 Candidates for BCT: Tumor to breast size ratio allows for acceptable cosmetic result No evidence of diffuse calcifications on mammogram 3 Candidates for limited axillary surgery with a prior biopsy proven axillary lymph node metastasis must have documented removal of the prior biopsied and clipped lymph node. Preferred approach is targeted ...

  Breast, Prior, Mammogram